Loster Tablets

Description

Loster is indicated as an adjunct to diet to reduce elevated total-C,LDL-C,ApoB, non HDL-C in adult patients with primary hypercholesterolemia(heterozygous familial and non- familial) and mixed dyslipidemia (Frederickson type IIA and IIB).
As an adjunct to diet for the treatment of patients with elevated serum TG levels (Frederickson type IV). To reduce LDL-C, total-C and APOB in patients with homozygous familial hypercholesterolemia as adjunct to lipid-lowering treatment (e.g, LDL apheresis) or if such treatment is unavailable.